<table class="infobox infobox-protein">
<tr>
<th class="infobox-header" colspan="2">CAPRIN1 Protein</th>
</tr>
<tr>
<td class="label">Gene</td>
<td>[CAPRIN1](/genes/caprin1)</td>
</tr>
<tr>
<td class="label">UniProt ID</td>
<td>[Q14444](https://www.uniprot.org/uniprot/Q14444)</td>
</tr>
<tr>
<td class="label">Molecular Weight</td>
<td>~78 kDa</td>
</tr>
<tr>
<td class="label">Length</td>
<td>709 amino acids</td>
</tr>
<tr>
<td class="label">Subcellular Localization</td>
<td>Cytoplasm, stress granules</td>
</tr>
<tr>
<td class="label">Protein Family</td>
<td>CAPRIN family</td>
</tr>
<tr>
<td class="label">Domain Architecture</td>
<td>RRM, RG-rich, prion-like domains</td>
</tr>
<tr>
<td class="label">Brain Region</td>
<td>Expression Level</td>
</tr>
<tr>
<td class="label">Cerebral Cortex</td>
<td>High</td>
</tr>
<tr>
<td class="label">Hippocampus</td>
<td>High</td>
</tr>
<tr>
<td class="label">Cerebellum</td>
<td>High</td>
</tr>
<tr>
<td class="label">Spinal Cord</td>
<td>High</td>
</tr>
<tr>
<td class="label">Brainstem</td>
<td>Moderate</td>
</tr>
<tr>
<td class="label">Protein</td>
<td>Interaction</td>
</tr>
<tr>
<td class="label">TDP-43</td>
<td>Co-localization in stress granules</td>
</tr>
<tr>
<td class="label">FUS</td>
<td>RNA-binding partner, co-trafficking</td>
</tr>
<tr>
<td class="label">G3BP1</td>
<table class="infobox infobox-protein">
<tr>
<th class="infobox-header" colspan="2">CAPRIN1 Protein</th>
</tr>
<tr>
<td class="label">Gene</td>
<td>[CAPRIN1](/genes/caprin1)</td>
</tr>
<tr>
<td class="label">UniProt ID</td>
<td>[Q14444](https://www.uniprot.org/uniprot/Q14444)</td>
</tr>
<tr>
<td class="label">Molecular Weight</td>
<td>~78 kDa</td>
</tr>
<tr>
<td class="label">Length</td>
<td>709 amino acids</td>
</tr>
<tr>
<td class="label">Subcellular Localization</td>
<td>Cytoplasm, stress granules</td>
</tr>
<tr>
<td class="label">Protein Family</td>
<td>CAPRIN family</td>
</tr>
<tr>
<td class="label">Domain Architecture</td>
<td>RRM, RG-rich, prion-like domains</td>
</tr>
<tr>
<td class="label">Brain Region</td>
<td>Expression Level</td>
</tr>
<tr>
<td class="label">Cerebral Cortex</td>
<td>High</td>
</tr>
<tr>
<td class="label">Hippocampus</td>
<td>High</td>
</tr>
<tr>
<td class="label">Cerebellum</td>
<td>High</td>
</tr>
<tr>
<td class="label">Spinal Cord</td>
<td>High</td>
</tr>
<tr>
<td class="label">Brainstem</td>
<td>Moderate</td>
</tr>
<tr>
<td class="label">Protein</td>
<td>Interaction</td>
</tr>
<tr>
<td class="label">TDP-43</td>
<td>Co-localization in stress granules</td>
</tr>
<tr>
<td class="label">FUS</td>
<td>RNA-binding partner, co-trafficking</td>
</tr>
<tr>
<td class="label">G3BP1</td>
<td>Core stress granule component</td>
</tr>
<tr>
<td class="label">TIA1</td>
<td>Granule scaffolding protein</td>
</tr>
<tr>
<td class="label">hnRNPA1</td>
<td>Alternative splicing regulation</td>
</tr>
<tr>
<td class="label">OPTN</td>
<td>Autophagy receptor for granule clearance</td>
</tr>
<tr>
<td class="label">Approach</td>
<td>Description</td>
</tr>
<tr>
<td class="label">Stress granule modulators</td>
<td>Normalize granule dynamics</td>
</tr>
<tr>
<td class="label">RNA-based therapeutics</td>
<td>Target disease-associated RNAs</td>
</tr>
<tr>
<td class="label">Protein aggregation inhibitors</td>
<td>Prevent toxic aggregation</td>
</tr>
<tr>
<td class="label">Neuroprotective agents</td>
<td>Support motor neuron survival</td>
</tr>
<tr>
<td class="label">Small molecule inhibitors</td>
<td>Target CAPRIN1-protein interactions</td>
</tr>
<tr>
<td class="label">Antisense oligonucleotides</td>
<td>Modulate CAPRIN1 expression</td>
</tr>
<tr>
<td class="label">Associated Diseases</td>
<td><a href="/wiki/als" style="color:#ef9a9a">Als</a>, <a href="/wiki/autism" style="color:#ef9a9a">Autism</a>, <a href="/wiki/ms" style="color:#ef9a9a">Ms</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">9 edges</a></td>
</tr>
</table>
CAPRIN1 (Cell Cycle Associated Protein 1, also known as RNG105 or Hu-PRLP) is a 709-amino acid RNA-binding protein that plays critical roles in stress granule formation, mRNA transport, and translational regulation in neurons. Originally identified as a regulator of cell cycle progression, CAPRIN1 has emerged as a key player in neurodegenerative diseases, particularly amyotrophic lateral sclerosis (ALS), frontotemporal dementia (FTD), and Alzheimer's disease [1].
:: infobox .infobox-protein
===
CAPRIN1 contains several functional domains that enable its diverse cellular functions:
CAPRIN1 is a key node in the stress-responsive translational machinery [1]:
CAPRIN1 facilitates dendritic mRNA transport in neurons [5]:
CAPRIN1 modulates translation initiation and elongation:
CAPRIN1 is widely expressed in the nervous system:
High expression in motor neurons correlates with the vulnerability of these cells in ALS [2].
CAPRIN1 is strongly implicated in ALS pathogenesis [3]:
CAPRIN1 connects to FTD through shared mechanisms with ALS:
CAPRIN1 has emerging roles in AD:
CAPRIN1 undergoes liquid-liquid phase separation [10]:
CAPRIN1 interacts with multiple disease-relevant proteins:
CAPRIN1 affects multiple aspects of RNA metabolism:
Stress granule function declines with age [11]:
These age-related changes may contribute to increased neurodegeneration susceptibility in the elderly.
CAPRIN1 has potential as a disease biomarker:
Several models illuminate CAPRIN1 function:
Key experimental approaches: